Khanna R - Search Results

1

Erratum to: Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview.

Hindryckx P, Novak G, Vande Casteele N, Khanna R, Laukens D, Jairath V, Feagan BG. Hindryckx P, et al. Among authors: khanna r. Drugs. 2017 Mar;77(4):379. doi: 10.1007/s40265-017-0719-z. Drugs. 2017. PMID: 28247265 No abstract available.

2

Through the looking glass: a journey toward optimal endoscopic assessment of disease activity in ulcerative colitis.

Khanna R, Feagan BG. Khanna R, et al. Clin Gastroenterol Hepatol. 2013 Jan;11(1):55-6. doi: 10.1016/j.cgh.2012.09.024. Epub 2012 Sep 27. Clin Gastroenterol Hepatol. 2013. PMID: 23022700 No abstract available.

3

Biosimilars in IBD: hope or expectation?

Gecse KB, Khanna R, van den Brink GR, Ponsioen CY, Löwenberg M, Jairath V, Travis SP, Sandborn WJ, Feagan BG, D'Haens GR. Gecse KB, et al. Among authors: khanna r. Gut. 2013 Jun;62(6):803-7. doi: 10.1136/gutjnl-2012-303824. Epub 2013 Mar 16. Gut. 2013. PMID: 23503043 Review. No abstract available.

4

Ustekinumab for the treatment of Crohn's disease.

Khanna R, Feagan BG. Khanna R, et al. Immunotherapy. 2013 Aug;5(8):803-15. doi: 10.2217/imt.13.81. Immunotherapy. 2013. PMID: 23902548 Review.

5

Challenging question: is treating inflammatory bowel disease an art or strictly an evidence-based matter?

Khanna R, Mosli MH, Feagan BG. Khanna R, et al. Dig Dis. 2013;31(2):213-7. doi: 10.1159/000353371. Epub 2013 Sep 6. Dig Dis. 2013. PMID: 24030228 Review.

6

Current and Future Status of Therapeutic Drug Monitoring in the Treatment of IBD.

Khanna R, Feagan BG. Khanna R, et al. Curr Treat Options Gastroenterol. 2014 Mar;12(1):76-89. doi: 10.1007/s11938-013-0005-4. Curr Treat Options Gastroenterol. 2014. PMID: 24395613

7

Therapeutic drug monitoring in inflammatory bowel disease: current state and future perspectives.

Vande Casteele N, Feagan BG, Gils A, Vermeire S, Khanna R, Sandborn WJ, Levesque BG. Vande Casteele N, et al. Among authors: khanna r. Curr Gastroenterol Rep. 2014 Apr;16(4):378. doi: 10.1007/s11894-014-0378-0. Curr Gastroenterol Rep. 2014. PMID: 24595615 Free article. Review.

8

Toward a personalized medicine approach to the management of inflammatory bowel disease.

Mosli MH, Sandborn WJ, Kim RB, Khanna R, Al-Judaibi B, Feagan BG. Mosli MH, et al. Among authors: khanna r. Am J Gastroenterol. 2014 Jul;109(7):994-1004. doi: 10.1038/ajg.2014.110. Epub 2014 May 20. Am J Gastroenterol. 2014. PMID: 24842338 Review.

9

A systematic review of measurement of endoscopic disease activity and mucosal healing in Crohn's disease: recommendations for clinical trial design.

Khanna R, Bouguen G, Feagan BG, DʼHaens G, Sandborn WJ, Dubcenco E, Baker KA, Levesque BG. Khanna R, et al. Inflamm Bowel Dis. 2014 Oct;20(10):1850-61. doi: 10.1097/MIB.0000000000000131. Inflamm Bowel Dis. 2014. PMID: 25029615 Review.

10

Assessment of histologic disease activity in Crohn's disease: a systematic review.

Mojtahed A, Khanna R, Sandborn WJ, D'Haens GR, Feagan BG, Shackelton LM, Baker KA, Dubcenco E, Valasek MA, Geboes K, Levesque BG. Mojtahed A, et al. Among authors: khanna r. Inflamm Bowel Dis. 2014 Nov;20(11):2092-103. doi: 10.1097/MIB.0000000000000155. Inflamm Bowel Dis. 2014. PMID: 25137418 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,141 results

Search Page

Filters